BOSTON (WHDH) - A Boston hospital is taking part in a study that could help prevent certain symptoms of Alzheimer’s disease.
Brigham and Women’s Hospital has been taking part in the global AHEAD study, which is testing a possible treatment for patients who are at-risk for developing Alzheimer’s.
Part of the study involves looking into the effectiveness of a drug called “Lecanemab,” and how the treatment could potentially slow or even stop early brain changes caused by the disease.
“The AHEAD study is really the first attempt of using a medication in a population who doesn’t yet have symptoms,” said lead researcher Dr. Seth Gale. “I hope that this is the beginning of a big paradigm shift in early detection and then ultimate prevention.”
The four-year study is still seeking local participants, according to officials. Those who are interested can find more information here.
(Copyright (c) 2022 Sunbeam Television. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)